SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on April 3, 2020, reporting events occurring on April 1, 2020. The registrant is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol LNDC.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on executive compensation adjustments.
Material Changes
The primary material change reported is the adjustment to the compensation package for Brian McLaughlin, Chief Financial Officer and Vice President of Finance and Administration, approved by the Compensation Committee on April 1, 2020:
- Annual Base Salary: Increased from $294,000 to $350,000.
- Annual Cash Target Bonus: Increased from 50% of base salary to 60% of base salary.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding business outlook, guidance, risks, contingencies, or unusual items. The document is limited to the disclosure of the officer's compensatory arrangements.
Investor Verification Checklist
- Verify the identity of the registrant as Landec Corporation (LNDC), noting the discrepancy with the requested company name (Lifecore Biomedical, Inc.).
- Confirm the effective date of the salary and bonus increase for the CFO (April 1, 2020).
- Review the total annual compensation impact, which includes a $56,000 increase in base salary and a proportional increase in the target bonus opportunity.